ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology1991
Role of gamma interferon in Toxoplasma gondii infection.
Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 55 citations in OpenAlex.
- A review of immune modulators and immunotherapy in infectious diseases.Molecular and cellular biochemistry · 2024Review
- Autophagy in protists and their hosts: When, how and why?Autophagy reports · 2023Article
- Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.Parasitology research · 2013Article
- Disruption of the expression of a non-coding RNA significantly impairs cellular differentiation in Toxoplasma gondii.International journal of molecular sciences · 2012Article
- ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18.The Journal of experimental medicine · 2011Article
- Impairment of host defense against disseminated candidiasis in mice overexpressing GATA-3.Infection and immunity · 2010Article
- The development and biology of bradyzoites of Toxoplasma gondii.Frontiers in bioscience : a journal and virtual library · 2000Review
- Changes in cytokine levels during reactivation of Toxoplasma gondii infection in lungs.Infection and immunity · 1999Article
- Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction.The Journal of experimental medicine · 1997Article
- Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion.Infection and immunity · 1994Article
- Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages.Infection and immunity · 1993Article
- Induction of heat shock protein closely correlates with protection against Toxoplasma gondii infection.Proceedings of the National Academy of Sciences of the United States of America · 1992Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Toxoplasma gondii has emerged as an important pathogen in the ever increasing numbers of patients with disorders of the immune system. Better understanding of the mechanisms of resistance of the host against this protozoan is important for development of safe, effective alternative treatment regimens for toxoplasmosis. Gamma interferon is the cytokine that plays a central role in protection against Toxoplasma gondii. The purpose of this review is to highlight the current knowledge of the role of gamma interferon in Toxoplasma gondii infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.